Scientific Director
Bristol Myers Squibb Company
Princeton, New Jersey
Dr. Hong Shen is a Scientific Director in the Department of Drug Metabolism and Pharmacokinetics (DMPK) at Bristol Myers Squibb, where he researches drug transporter activities and provides preclinical DMPK support for multiple drug discovery and development programs. He received his Ph.D. in Pharmaceutical Sciences under the supervision of Dr. David Smith at University of Michigan. Dr. Shen was in the organizing committee for the AAPS Drug Transporter Focus Group from 2014 to 2018. He is currently a committee member of the International Transporter Consortium (ITC), ISSX Transporter Focus Group, Pharmaceutical IQ DMLG/CPLG Transporter Working Group, and Pharmaceutical IQ DMLG/CPLG OATP1B Biomarker Working Group. He received the James Gillette Drug Metabolism and Pharmacokinetics Awards sponsored by the American Society for Pharmacology and Experimental Therapeutics in 2001, 2007, and 2018. He has over 80 research publications and book chapters. His research is focused on applying mechanism-based approaches for the quantitative translation of preclinical in vitro and in vivo data to clinical findings in order to broadly impact drug discovery and development processes involving drug transporters.
Monday, October 23, 2023
10:00 AM – 10:30 AM ET